Cytopenia Clinical Trials in New York, New York
6 recruitingNew York, New York
Showing 1–6 of 6 trials
Recruiting
Phase 1
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Antiphospholipid Syndrome (APS)Immune-mediated Necrotizing Myopathy (IMNM)Immune Thrombocytopenia (ITP)+3 more
Chugai Pharmaceutical144 enrolled69 locationsNCT06371417
Recruiting
Phase 2
Luspatercept for Clonal Cytopenias of Uncertain Significance
ThrombocytopeniaNeutropeniaAnemia+2 more
Weill Medical College of Cornell University50 enrolled1 locationNCT06788691
Recruiting
Phase 2
Open-Label, Phase II Trial of Isatuximab for Patients With Refractory Immune Cytopenias After Allogeneic Hematopoietic Cell Transplantation
Blood CancerRefractory Immune Cytopenias
Memorial Sloan Kettering Cancer Center12 enrolled7 locationsNCT05873205
Recruiting
Phase 2
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
MyelofibrosisModerate ThrombocytopeniaMild Thrombocytopenia
Karyopharm Therapeutics Inc58 enrolled70 locationsNCT05980806
Recruiting
Phase 2
Canakinumab for the Prevention of Progression to Cancer in Patients With Clonal Cytopenias of Unknown Significance, IMPACT Study
Clonal Cytopenia of Undetermined Significance
Uma Borate110 enrolled6 locationsNCT05641831
Recruiting
Phase 2
A Study of Emapalumab for Pediatric Aplastic Anemia
Aplastic AnemiaCytopeniaHypocellular Marrow
Memorial Sloan Kettering Cancer Center35 enrolled6 locationsNCT06430788